Corporate development in biotechnology in 2005
DOI:
https://doi.org/10.5912/jcb123Keywords:
consolidation, merger, acquisition, business modelAbstract
In 1998 the author produced two papers which argued that consolidation was a necessary activity for biotechnology companies to consider more. Three years later a further consideration of the subject was published. Corporate developments in biotechnology in the first decade of the 21st century are now considered.
Downloads
Issue
Section
Article